logo
Select company
Select metric
-135.06%Operating Cash Flow Margin
VS
Market
10
Sector
34
Industry
62
History
73
$ 2.7Close
$ 1.41 - $ 4 52-Week Range
Ticker Information

Ticker

FBIO

Company Name

FORTRESS BIOTECH INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

FORTRESS BIOTECH INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

FBIO - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ -80.09M-135.06%$ 59.3M
3/31/2025$ -74.37M-128.7%$ 57.78M
12/31/2024$ -80.19M-139.04%$ 57.67M
9/30/2024$ -102.22M-163.55%$ 62.5M
6/30/2024$ -98.94M-119.75%$ 82.62M
3/31/2024$ -110.39M-129.7%$ 85.11M
12/31/2023$ -128.22M-151.72%$ 84.51M
9/30/2023$ -141.13M-174.3%$ 80.97M
6/30/2023$ -167.63M-267.15%$ 62.75M
3/31/2023$ -175.76M-273.57%$ 64.25M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • FORTRESS BIOTECH INC's latest trailing twelve months (TTM) OCF % stands at -205.32%.
  • Over the past 5 years, FORTRESS BIOTECH INC's average OCF % has been -179.26%.
  • The median OCF % for FORTRESS BIOTECH INC during this period was -174.49%
  • FORTRESS BIOTECH INC reached its highest OCF % over the past 5 years at -119.75%.
  • The lowest OCF % recorded by FORTRESS BIOTECH INC in the same timeframe -273.57%

FORTRESS BIOTECH INC's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
DOMH : DOMINARI HOLDINGS INC -13.35%ICCC : IMMUCELL CORP 8.96%MGX : METAGENOMI INC -287.27%EQ : EQUILLIUM INC -133.74%ADAP : ADAPTIMMUNE THERAPEUTICS PLC -291.97%BRNS : BARINTHUS BIOTHERAPEUTICS PLC -254.68%MRSN : MERSANA THERAPEUTICS INC -229.39%VRCA : VERRICA PHARMACEUTICALS INC -321.97%IVVD : INVIVYD INC -244.77%IRD : OPUS GENETICS INC -206.41%

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for FORTRESS BIOTECH INC is calculated as follows: CF - Operations [ $ -88.25M ] / Revenues [ $ 42.98M ]
(=) OCF % [ -205.32% ]

FBIO - Operating Cash Flow Margin, Last 5 years

-273.57%

Minimum

Mar 31, 2023

-119.75%

Maximum

Jun 30, 2024

-179.26%

Average

-174.49%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.31% with a standard deviation of 21.13%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max77.08%
average14.31%
median12.65%
std21.13%